Emerald Bioventures

Aikium is a biotechnology company that specializes in developing novel protein therapeutics for neuro-inflammation and oncology. It combines advancements in synthetic biology and deep learning to create unique, non-antibody scaffold proteins that specifically target and bind to disordered regions of proteins, offering innovative solutions for clients to effectively address disordered proteins.

Bask Health is an e-commerce platform that specializes in telehealth solutions, providing a comprehensive suite of services for direct-to-consumer healthcare businesses. Its offerings include electronic medical records, payment processing, pharmacy fulfillment, website development, and patient management systems. By integrating these services, Bask Health enables merchants and healthcare providers to efficiently launch and scale their telehealth operations, facilitating seamless connections to essential resources. The platform aims to simplify the process of e-prescribing and enhance the overall patient experience in the digital healthcare landscape.

eGlint develops biosensing technology and devices designed to deliver rapid, multiplexed biomarker analysis. The company is advancing a miniature biosensing device that uses a small blood sample to derive data on multiple biomarkers, and a real-time proteomics platform that measures hundreds of biomarkers within minutes. Its multiplexed, quantitative, and scalable approach provides actionable medical insights for point-of-care and clinical settings, enabling healthcare providers and researchers to obtain diagnostic information quickly from a single test.

Health Outlook is a healthcare startup focused on improving predictions of longevity and health events through advanced statistical models. The company utilizes proprietary algorithms that integrate traditional mortality risk factors with modern proteomic markers, allowing for more accurate assessments of health risks. By leveraging these innovative techniques, Health Outlook aims to enhance life expectancy predictions and enable clients in the financial services and health systems markets to make informed decisions based on improved health analytics. Through a common platform, the company is poised to launch various businesses that capitalize on its predictive capabilities, ultimately contributing to better health outcomes and longevity insights.